Personalis, Inc. Total Assets
Personalis, Inc. (PSNL) had Total Assets of $312.13 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Assets
us-gaap:Assets · last filed 2026-08-04
- 2026-06-30: Assets $312.13M.
- 2026-03-31: Assets $325.39M.
- 2025-12-31: Assets $334.16M.
- 2025-09-30: Assets $242.84M.
| Period end | Assets |
|---|---|
| 2026-06-30 | $312.13M 10-Q · filed 2026-08-04 |
| 2026-03-31 | $325.39M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $334.16M 10-Q · filed 2026-08-04 |
| 2025-09-30 | $242.84M 10-Q · filed 2025-11-04 |
| 2025-06-30 | $258.68M 10-Q · filed 2025-08-05 |
| 2025-03-31 | $273.31M 10-Q · filed 2025-05-06 |
| 2024-12-31 | $270.27M 10-K · filed 2026-02-26 |
| 2024-09-30 | $239.89M 10-Q · filed 2024-11-06 |
| 2024-06-30 | $185.50M 10-Q · filed 2024-08-07 |
| 2024-03-31 | $195.28M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $225.10M 10-K · filed 2025-02-27 |
| 2023-09-30 | $226.64M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $249.04M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $272.18M 10-Q · filed 2023-05-03 |
| 2022-12-31 | $292.70M 10-K · filed 2024-02-28 |
| 2022-09-30 | $317.86M 10-Q · filed 2022-11-02 |
| 2022-06-30 | $357.98M 10-Q · filed 2022-08-03 |
| 2022-03-31 | $380.65M 10-Q · filed 2022-05-04 |
| 2021-12-31 | $396.53M 10-K · filed 2023-02-23 |
| 2021-09-30 | $406.69M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $383.34M 10-Q · filed 2021-08-04 |
| 2021-03-31 | $395.51M 10-Q · filed 2021-05-05 |
| 2020-12-31 | $244.84M 10-K · filed 2022-02-24 |
| 2020-09-30 | $248.81M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $145.52M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $151.88M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $157.29M 10-K · filed 2021-02-25 |
| 2019-09-30 | $159.69M 10-Q · filed 2019-11-13 |
| 2019-06-30 | $191.84M 10-Q · filed 2019-08-13 |
| 2018-12-31 | $41.67M 10-K · filed 2020-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |